Table 3.

Threshold unit costs of the biomarker test variants allowed for equal cost-effectiveness compared to FIT.

Sensitivity CRC (%)*	Specificity
	88	90	92	94	96	98	100
60	−1	−1	1	3	6	8	11
70	6	9	9	12	14	17	19
80	15	17	19	21	23	25	27
90	25	27	29	32	34	35	36
100	38	40	42	44	46	48	50

CRC, colorectal cancer; FIT, fecal immunochemical test; Neg., calculated threshold cost was a negative value.

^*Although the average sensitivity for CRC is used to label the different biomarker test variants, the sensitivity for adenomas is varied accordingly (see Table 1).

^†The presented unit costs include costs for the test kit and the analysis of the test.